13.49 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Atrium Therapeutics, Inc. Common Stock
RNANASDAQ • USD
13.50
↗ 0.01 (0.07%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
13.50
↗ 0.01 (0.07%)
Market: CLOSED
Open?$13.78
High?$13.78
Low?$13.46
Prev. Close?$13.49
Volume?196.6K
Avg. Volume?N/A
VWAP?$13.65
Bid / Ask
Bid?$10.53 × 100
Ask?$16.88 × 100
Spread?$6.35
Midpoint?$13.70
Valuation & Ratios
Market Cap?209.3M
Shares Out?17.1M
Float?16.2M
Float %?94.9%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
xxx
Related Companies
Loading...
News
Profile
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.